On 17 August 2018 and on 26 October 2018, the Global Fund Board approved two HIV grants and three TB grants worth $28.1 million. The Board also approved $15.9 million in matching funds requests for six components.
In an audit of grants to Côte d’Ivoire, the Office of the Inspector General (OIG) rated grant implementation arrangements as being “partially effective”; and supply chain controls and assurance mechanisms as “needing significant improvement.”
The OIG uses a four-tier rating system: Effective; Partially effective; Needs significant improvement; and Ineffective.
The Global Fund’s I Speak Out Now! campaign encourages the reporting of fraud and corruption easily through online reporting
On International Anti-Corruption day, 09 December 2015, the Global Fund's Office of the Inspector General (OIG) launched its campaign to raise awareness about fraud and abuse of Global Fund money.
As reported in GFO #295, in August the Board approved $180 million in funding for 14 grants from 11 countries. The Board was acting on recommendations of the Technical Review Panel (TRP) and the Grants Approvals Committee (GAC). This article provides a summary of the some of the comments made by the GAC in its report to the Board.
En Côte d’Ivoire, 2 millions de doses de médicament antituberculeux détournées sur les marchés locaux
En Côte d’Ivoire, la Nouvelle Pharmacie de la Santé Publique (NPSP), l’entité de chargée de recevoir, stocker et distribuer les médicaments, ainsi qu’un récipiendaire principal, le Programme National de Lutte contre la Tuberculose (PNLT) sont à l’origine d’un vaste détournement de médicaments antituberculeux de première ligne financés par le Fonds mondial.
In Côte d’Ivoire, the Nouvelle Pharmacie de la Santé Publique (NPSP), the facility responsible for receiving, warehousing and distributing medicines, and the Programme National de Lutte contre la Tuberculose (PNLT), a principal recipient, were responsible for a massive diversion of TB drugs financed by The Global Fund.